627 related articles for article (PubMed ID: 18386288)
1. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
2. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
[TBL] [Abstract][Full Text] [Related]
3. Trypsin stimulates the phosphorylation of p42,44 mitogen-activated protein kinases via the proteinase-activated receptor-2 and protein kinase C epsilon in human cultured prostate stromal cells.
Myatt A; Hill SJ
Prostate; 2005 Jul; 64(2):175-85. PubMed ID: 15678497
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
7. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
8. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
Ropiquet F; Giri D; Lamb DJ; Ittmann M
J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
[TBL] [Abstract][Full Text] [Related]
9. PKC isoenzymes differentially modulate the effect of thrombin on MAPK-dependent RPE proliferation.
Palma-Nicolas JP; López E; López-Colomé AM
Biosci Rep; 2008 Dec; 28(6):307-17. PubMed ID: 18636965
[TBL] [Abstract][Full Text] [Related]
10. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells.
Liu J; Schuff-Werner P; Steiner M
Biochem Biophys Res Commun; 2006 Apr; 343(1):183-9. PubMed ID: 16530725
[TBL] [Abstract][Full Text] [Related]
11. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
Lin VK; Wang SY; Boetticher NC; Vazquez DV; Saboorian H; McConnell JD; Roehrborn CG
Prostate; 2005 May; 63(3):299-308. PubMed ID: 15611997
[TBL] [Abstract][Full Text] [Related]
12. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
13. The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release.
Ostrowska E; Reiser G
Cell Mol Life Sci; 2008 Mar; 65(6):970-81. PubMed ID: 18264801
[TBL] [Abstract][Full Text] [Related]
14. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells.
Story MT; Hopp KA; Meier DA
Prostate; 1996 Apr; 28(4):219-26. PubMed ID: 8602397
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1.
Wang W; Mize GJ; Zhang X; Takayama TK
Int J Cancer; 2010 Feb; 126(3):599-610. PubMed ID: 19795418
[TBL] [Abstract][Full Text] [Related]
16. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
[TBL] [Abstract][Full Text] [Related]
17. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
Giri D; Ropiquet F; Ittmann M
J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
[TBL] [Abstract][Full Text] [Related]
19. Stromal cells of the human prostate: initial isolation and characterization.
Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
Ho CK; Nanda J; Chapman KE; Habib FK
J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]